New York · 2025 Regular Session · Bill
S 5012: Prohibits health insurers from requiring prior authorization for anti-retroviral medication used to treat and prevent HIV infection
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 5012 is a bill introduced in the New York Senate on February 18, 2025. According to its official title, it concerns: Prohibits health insurers from requiring prior authorization for anti-retroviral medication used to treat and prevent HIV infection. Primary sponsor: Pete Harckham (Democratic/Working Families). It lists 1 additional sponsor. Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Prohibits health insurers, health care plans and HMOs from requiring prior authorization for anti-retroviral medication used to treat and prevent HIV infection.
Sponsors
Sponsors by party (alphabetical): Democratic/Working Families 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Pete Harckham | Primary sponsor | Democratic/Working Families | Senate | 40 |
| Lea Webb | Co-sponsor | Democratic/Working Families | Senate | 52 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH
- REFERRED TO HEALTH